Metoprolol Succinate - NDC Database (Page 23)
465 records found
Page:
72162-1858 Nov 27, 2020
Metoprolol Succinate 100 mg Oral Tablet, Film Coated, Extended Release by Bryant Ranch Prepack
Metoprolol Succinate 100 mg Oral Tablet, Film Coated, Extended Release by Bryant Ranch Prepack
72162-1859 Nov 27, 2020
Metoprolol Succinate 200 mg Oral Tablet, Film Coated, Extended Release by Bryant Ranch Prepack
Metoprolol Succinate 200 mg Oral Tablet, Film Coated, Extended Release by Bryant Ranch Prepack
72516-030 Apr 27, 2022
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
72516-031 Apr 27, 2022
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
72516-032 Apr 27, 2022
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
72516-033 Apr 27, 2022
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Oryza Pharmaceuticals, Inc
72603-144 Apr 10, 2023
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Northstar Rx LLC
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Northstar Rx LLC
72603-145 Apr 10, 2023
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Northstar Rx LLC
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Northstar Rx LLC
72789-010 Feb 06, 2018
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
72789-107 Oct 01, 2019
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
72789-145 Oct 01, 2019
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
72789-284 Sep 10, 2012
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Pd-rx Pharmaceuticals, Inc.
75834-290 Feb 26, 2021
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
75834-291 Feb 26, 2021
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
75834-292 Feb 26, 2021
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
Metoprolol Succinate 100 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
75834-293 Feb 26, 2021
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
Metoprolol Succinate 200 mg Oral Tablet, Extended Release by Nivagen Pharmaceuticals, Inc.
82009-113 Jul 20, 2023
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Quallent Pharmaceuticals Health LLC
Metoprolol Succinate 25 mg Oral Tablet, Extended Release by Quallent Pharmaceuticals Health LLC
82009-114 Jul 20, 2023
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Quallent Pharmaceuticals Health LLC
Metoprolol Succinate 50 mg Oral Tablet, Extended Release by Quallent Pharmaceuticals Health LLC
Page:
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.